JP2010524895A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524895A5
JP2010524895A5 JP2010503512A JP2010503512A JP2010524895A5 JP 2010524895 A5 JP2010524895 A5 JP 2010524895A5 JP 2010503512 A JP2010503512 A JP 2010503512A JP 2010503512 A JP2010503512 A JP 2010503512A JP 2010524895 A5 JP2010524895 A5 JP 2010524895A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
cyano
imidazol
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010503512A
Other languages
English (en)
Japanese (ja)
Other versions
JP5675342B2 (ja
JP2010524895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/054712 external-priority patent/WO2008128983A1/en
Publication of JP2010524895A publication Critical patent/JP2010524895A/ja
Publication of JP2010524895A5 publication Critical patent/JP2010524895A5/ja
Application granted granted Critical
Publication of JP5675342B2 publication Critical patent/JP5675342B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010503512A 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのシアノグアニジン誘導体 Expired - Fee Related JP5675342B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91252807P 2007-04-18 2007-04-18
US60/912,528 2007-04-18
PCT/EP2008/054712 WO2008128983A1 (en) 2007-04-18 2008-04-18 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors

Publications (3)

Publication Number Publication Date
JP2010524895A JP2010524895A (ja) 2010-07-22
JP2010524895A5 true JP2010524895A5 (https=) 2011-05-26
JP5675342B2 JP5675342B2 (ja) 2015-02-25

Family

ID=39639502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503512A Expired - Fee Related JP5675342B2 (ja) 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのシアノグアニジン誘導体

Country Status (6)

Country Link
US (1) US8227498B2 (https=)
EP (1) EP2160380B1 (https=)
JP (1) JP5675342B2 (https=)
DK (1) DK2160380T3 (https=)
ES (1) ES2474693T3 (https=)
WO (1) WO2008128983A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) * 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP5676249B2 (ja) * 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
CA2696934A1 (en) * 2007-09-12 2010-02-16 Probiodrug Ag Transgenic mice
NZ586665A (en) * 2008-01-14 2011-12-22 Probiodrug Ag MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE GLUTAMINYL CYCLASE GENE (Qpct)
EP2320942B1 (en) 2008-07-21 2018-03-14 Probiodrug AG Diagnostic antibody assay
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
WO2011076854A1 (en) 2009-12-22 2011-06-30 Probiodrug Ag CLEAVAGE OF β-AMYLOID PRECURSOR PROTEIN
EP2537029A1 (en) 2010-02-18 2012-12-26 Probiodrug AG Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and screening methods for inhibitors of glutaminyl cyclase
BR112013023211B1 (pt) 2011-03-16 2022-11-08 Vivoryon Therapeutics N.V. Anticorpo monoclonal, seu uso, composição, linhagem celular, método diagnóstico in vitro e kit
US20130052203A1 (en) * 2011-08-12 2013-02-28 Probiodrug Ag In vivo screening models for treatment of qc-related disorders
CA2879454A1 (en) 2012-07-19 2014-01-23 Drexel University Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
WO2016097305A1 (en) 2014-12-19 2016-06-23 Probiodrug Ag Novel method for the detection of pglu-abeta peptides
AU2018308191B2 (en) 2017-07-24 2023-12-21 Scenic Immunology B.V. Treating pathological conditions by direct and indirect targeting of SIRPa - CD47 interaction
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
WO2019089902A1 (en) 2017-11-01 2019-05-09 Drexel University Compounds, compositions, and methods for treating diseases
EP3521308B1 (en) 2018-01-31 2024-03-13 Vivoryon Therapeutics N.V. Humanized and de-immunized antibodies
JP7751894B2 (ja) * 2021-03-30 2025-10-09 ナミックス株式会社 硬化触媒、樹脂組成物、封止材、接着剤、及び硬化物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044566A1 (de) * 1980-11-26 1982-07-15 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
KR20010012326A (ko) * 1997-05-07 2001-02-15 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 치환 3,3-디아미노-2-프로펜니트릴, 그것의 제조방법 및사용
US6948038B2 (en) * 2001-07-24 2005-09-20 Microsoft Corporation System and method for backing up and restoring data
US7732162B2 (en) * 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8338120B2 (en) * 2003-05-05 2012-12-25 Probiodrug Ag Method of treating inflammation with glutaminyl cyclase inhibitors
JP4806628B2 (ja) * 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
KR20110059664A (ko) * 2003-05-05 2011-06-02 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
BRPI0415409A (pt) * 2003-10-15 2006-12-05 Probiodrug Ag uso de efetuadores de ciclases de glutaminila e glutamato
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
EP2338490A3 (en) * 2003-11-03 2012-06-06 Probiodrug AG Combinations useful for the treatment of neuronal disorders
US7667044B2 (en) * 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
US7304086B2 (en) * 2004-02-05 2007-12-04 Probiodrug Ag Inhibitors of glutaminyl cyclase
BRPI0718507A2 (pt) * 2006-09-21 2013-11-12 Probiodrug Ag Genes relacionados à glutaminil ciclase
US8420684B2 (en) * 2006-11-09 2013-04-16 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5599614B2 (ja) * 2006-11-09 2014-10-01 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
US9126987B2 (en) * 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP2010516235A (ja) * 2007-01-19 2010-05-20 プロビオドルグ エージー アルツハイマー病及び他のqpct関連障害の治療のためのインビボスクリーニングモデル
US7803810B2 (en) * 2007-03-09 2010-09-28 Probiodrug Ag Inhibitors

Similar Documents

Publication Publication Date Title
JP2010524895A5 (https=)
JP2010524898A5 (https=)
JP2010524893A5 (https=)
JP2010524899A5 (https=)
JP2010524897A5 (https=)
JP2010524896A5 (https=)
JP2010511013A5 (https=)
JP2010509284A5 (https=)
JP2010509285A5 (https=)
JP2010509286A5 (https=)
JP2013504544A5 (https=)
JP2013521325A5 (https=)
JP2010520869A5 (https=)
JP2013521260A5 (https=)
JP2020512373A5 (https=)
JP2014508184A5 (https=)
JP2013525334A5 (https=)
JP2012502006A5 (https=)
IL307911A (en) New inhibitors
JP2010507602A5 (https=)
JP2007524696A5 (https=)
JP2008514610A5 (https=)
JP2011509309A5 (https=)
MX2012010115A (es) Compuestos para el tratamiento de cancer.
EA022420B1 (ru) Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5)